Naglazyme 68135-0020-01

Generic: Galsulfase

Package NDC

68135-0020-01

Manufacturer: Biomarin Pharmaceutical Inc.
Dosage Form: Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: June 9, 2005
Listing Expires: December 31, 2026
Application: BLA125117

Need to source Naglazyme? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Galsulfase	5 mg/5mL

Drug Class

Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]alpha-Glucosidases [CS]

Selected Package

68135-0020-01Selected

1 VIAL in 1 CARTON (68135-020-01) / 5 mL in 1 VIAL